Imaging tau pathology in Parkinsonisms
Abstract The recent development of positron emission tomography radiotracers targeting pathological tau in vivo has led to numerous human trials. While investigations have primarily focused on the most common tauopathy, Alzheimer’s disease, it is imperative that testing also be performed in parkinso...
Saved in:
Main Authors: | Sarah Coakeley, Antonio P. Strafella |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/6afea461ad4e4fbcb28d678c014008db |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
by: Paula Ramos-Gonzalez, et al.
Published: (2021) -
Imaging Parkinson’s disease below the neck
by: Per Borghammer, et al.
Published: (2017) -
Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease
by: Chun Chen, et al.
Published: (2021) -
Optimizing Parkinson’s disease diagnosis: the role of a dual nuclear imaging algorithm
by: J. William Langston, et al.
Published: (2018) -
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
by: Moxin Wu, et al.
Published: (2021)